ArticleAnnals of translational medicine2021

Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study.

Xinrui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.